Business Description
Proteomics International Laboratories Ltd
ISIN : AU000000PIQ0
Description
Proteomics International Laboratories Ltd is a biological research and drug discovery company. The company specializes in the area of proteomics which is the industrial-scale study of the structure and function of proteins. Its operations are divided into PromarkerD which targets the diabetes epidemic and is a predictive diagnostic test for diabetic kidney disease, a progressive disorder found in one in three adults with diabetes; its proprietary biomarker discovery platform called Promarker, which searches for protein fingerprints in a sample; and Analytical Services that are specialist contract research focusing on biosimilars quality control and pharmacokinetic testing for clinical trials.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 108.04 | |||||
| Equity-to-Asset | 0.77 | |||||
| Debt-to-Equity | 0.01 | |||||
| Debt-to-EBITDA | -0.01 | |||||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | 44.47 | |||||
| Beneish M-Score | -4.53 | |||||
| WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -27.9 | |||||
| 3-Year EBITDA Growth Rate | -64.3 | |||||
| 3-Year EPS without NRI Growth Rate | -39.2 | |||||
| 3-Year FCF Growth Rate | -36.9 | |||||
| 3-Year Book Growth Rate | 12.9 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 39.05 | |||||
| 9-Day RSI | 42.4 | |||||
| 14-Day RSI | 45.71 | |||||
| 6-1 Month Momentum % | 17.51 | |||||
| 12-1 Month Momentum % | 25.3 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.34 | |||||
| Quick Ratio | 4.34 | |||||
| Cash Ratio | 4.16 | |||||
| Days Sales Outstanding | 114.76 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -9.4 | |||||
| Shareholder Yield % | -2.45 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -1499.83 | |||||
| Net Margin % | -1036.66 | |||||
| FCF Margin % | -985.03 | |||||
| ROE % | -86.51 | |||||
| ROA % | -69.56 | |||||
| ROIC % | -322.46 | |||||
| ROC (Joel Greenblatt) % | -407.51 | |||||
| ROCE % | -115.28 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 218 | |||||
| PB Ratio | 24.77 | |||||
| Price-to-Tangible-Book | 27.38 | |||||
| EV-to-EBIT | -15.89 | |||||
| EV-to-EBITDA | -17.09 | |||||
| EV-to-Revenue | 238.22 | |||||
| EV-to-FCF | -24.07 | |||||
| Price-to-Net-Current-Asset-Value | 36.5 | |||||
| Price-to-Net-Cash | 36.5 | |||||
| Earnings Yield (Greenblatt) % | -6.3 | |||||
| FCF Yield % | -3.99 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Proteomics International Laboratories Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil A$) | 0.581 | ||
| EPS (TTM) (A$) | -0.049 | ||
| Beta | 0.08 | ||
| Volatility % | 40.8 | ||
| 14-Day RSI | 45.71 | ||
| 14-Day ATR (A$) | 0.063169 | ||
| 20-Day SMA (A$) | 1.152 | ||
| 12-1 Month Momentum % | 25.3 | ||
| 52-Week Range (A$) | 0.7 - 1.4 | ||
| Shares Outstanding (Mil) | 130.89 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Proteomics International Laboratories Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Proteomics International Laboratories Ltd Stock Events
| Event | Date | Price(A$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Proteomics International Laboratories Ltd Frequently Asked Questions
What is Proteomics International Laboratories Ltd(ASX:PIQ)'s stock price today?
The current price of ASX:PIQ is A$1.10. The 52 week high of ASX:PIQ is A$1.40 and 52 week low is A$0.70.
When is next earnings date of Proteomics International Laboratories Ltd(ASX:PIQ)?
The next earnings date of Proteomics International Laboratories Ltd(ASX:PIQ) is .
Does Proteomics International Laboratories Ltd(ASX:PIQ) pay dividends? If so, how much?
Proteomics International Laboratories Ltd(ASX:PIQ) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers